Advertisement

Atlas of AIDS pp 154-165 | Cite as

Metabolic Manifestations

  • Carl Grunfeld
  • Peter Jensen
  • Phyllis C. Tien

Keywords

Growth Hormone Human Immunodeficiency Virus Infection Caloric Intake Acquire Immunodeficiency Syndrome Rest Energy Expenditure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kotler DP, Tierney AR, Wang J, Pierson RN Jr: Magnitude of body-cell-mass depletion and timing of death from wasting in AIDS. Am J Clin Nutr 1989, 50:444–447.PubMedGoogle Scholar
  2. 2.
    Grunfeld C, Pang M, Doerrler W, et al.: Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992, 74:1045–1052.PubMedCrossRefGoogle Scholar
  3. 3.
    Grunfeld C, Kotier DP, Shigenaga JK, et al.: Circulating interferon-α levels and hypertriglyceridema in the acquired immunodeficiency syndrome. Am J Med 1991, 90:154–162.PubMedGoogle Scholar
  4. 4.
    Hellerstein MK, Grunfeld C, Wu K, et al.: Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 1993, 76:559–565.PubMedCrossRefGoogle Scholar
  5. 5.
    Mildvan D, Machado SG, Wilets I, Grossberg SE: Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 1992, 339:453–456.PubMedCrossRefGoogle Scholar
  6. 6.
    Grunfeld C, Kotier DP, Hamadeh R, et al.: Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 1989, 86:27–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Grunfeld C, Pang M, Doerrier W, et al.: Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism 1993, 42:1270–1276.PubMedCrossRefGoogle Scholar
  8. 8.
    Grunfeld C, Pang M, Shimizu L, et al.: Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection the acquired immunodeficiency syndrome. Am J Clin Nutr 1992, 55:455–460.PubMedGoogle Scholar
  9. 9.
    Macallan DC, Noble C, Baldwin C, et al.: Prospective analysis of weight changes in IV human immunodeficiency virus infection. Am J Clin Nutr 1993, 58:417–424.PubMedGoogle Scholar
  10. 10.
    Macallan DC, Noble C, Baldwin C, et al.: Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 1995, 333:83–88.PubMedCrossRefGoogle Scholar
  11. 11.
    Grunfeld C, Feingold KR: Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992, 327:329–337.PubMedCrossRefGoogle Scholar
  12. 12.
    Kotier DP, Tierney AR, Culpepper-Morgan JA, et al.: Effect of home total parenteral nutrition on body composition in patients with acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr 1990, 14:454–458.CrossRefGoogle Scholar
  13. 13.
    Von Roenn JH, Armstrong D, Kotler DP, et al.: Megestrol acetate in patients with AIDS related cachexia. Ann Int Med 1994, 121:393–399.PubMedCrossRefGoogle Scholar
  14. 14.
    Oster MH, Enders SR, Samuels SJ, et al.: Megestrol acetate in patients with AIDS and cachexia. Ann Int Med 1994, 121:400–408.PubMedCrossRefGoogle Scholar
  15. 15.
    Mulligan K, Grunfeld C, Hellerstein MK, et al.: Anabolic effects of recombinant growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 1993, 77:956–962PubMedCrossRefGoogle Scholar
  16. 16.
    Schambelan M, Mulligan K, Grunfeld C, et al.: Recombinant human growth hormone in patients with HIV-associated wasting diesease. a randomized, placebo-controlled trial. Serostim Study Group. Ann Intern Med 1996, 125:873–882.PubMedCrossRefGoogle Scholar
  17. 17.
    Mulligan K, Grunfeld C, Tai VW, et al.: Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection. J Acquir Immune Defic Syndro 2000, 25:35–43.Google Scholar

Selected Bibliography

  1. Grunfeld C, Feingold KR: Body weight as essential data in the management of patients with human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 1993, 58:317–318.PubMedGoogle Scholar
  2. Grunfeld C, Feingold KR: Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 1992, 327:329–337.PubMedCrossRefGoogle Scholar
  3. Grunfeld C, Schambelan:The wasting syndrome. In Textbook of AIDS Medicine, edn 2. Edited by Merigan TC, Bartlett JG, Bolognesi DP. Baltimore: Williams and Wilkins; 1999:643–659.Google Scholar
  4. Kotier DP, Grunfeld C: Pathophysiology and treatment of the AIDS wasting syndrome. In Volberding P, Jacobson MA (eds.): AIDS Clinical Review. New York: Marcel Dekker, 1995.Google Scholar
  5. Macallan DC, Noble C, Baldwin C, et al.: Prospective analysis of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 1993, 58:417–424.PubMedGoogle Scholar
  6. Safrin S, Grunfeld C:Fat distribution and metabolic changes in patients with HIV infection. AIDS 1999, 13:2493–2505.PubMedCrossRefGoogle Scholar
  7. Schambelan M, Grunfeld C: Endocrine abnormalities associated with human immunodeficiency virus infection and AIDS. In Broder S, Merigan T, Bolognesi DP (eds.): Textbook of AIDS Medicine. Baltimore: Williams & Wilkins, 1994.Google Scholar
  8. Sellmeyer DE, Grunfeld C, Schambelan M:Endocrine abnormalities associated with HIV infection and AIDS. In Textbook of AIDS Medicine, edn 2. Edited by Merigan TC, Bartlett JG, Bolognesi DP. Baltimore: Williams and Wilkins; 1999:643–659.Google Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Carl Grunfeld
  • Peter Jensen
  • Phyllis C. Tien

There are no affiliations available

Personalised recommendations